Bayer gets FDA nod for app-connected injector for MS patients

Bayer recently received FDA approval for a connected auto-injector for relapsing-remitting multiple sclerosis medication and companion app. The device is called the  Betaconnect Electronic Autoinjector and the app, due out in July, is myBetaApp.
Source: mobihealthnews - Category: Information Technology Source Type: news